Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder-Reference-Cited by-同舟云学术

Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder

Published:2023-07 Issue: Volume:150 Page:209055
ISSN:2949-8759
Container-title:Journal of Substance Use and Addiction Treatment
language:en
Short-container-title:Journal of Substance Use and Addiction Treatment

Author:

Thakrar Ashish P.,Pytell Jarratt D.,Stoller Kenneth B.,Walters Vickie,Weiss Roger D.,Chander Geetanjali

Funder

National Institute on Drug Abuse

Publisher

Elsevier BV

Reference47 articles.

1. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research;Amato;Journal of Substance Abuse Treatment,2005

2. The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update;Journal of Addiction Medicine,2020

3. Data & Demographics—2020 Census Data,2021

4. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community;Biondi;ClinicalPractice,2022

5. Methadone and oral health – A brief;Brondani;Review,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl;JAMA Internal Medicine;2024-06-01

2. Oxycodone withdrawal is associated with increased cocaine self-administration and aberrant accumbens glutamate plasticity in rats;Neuropharmacology;2024-01

3. Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia;International Journal of Drug Policy;2023-12

4. Disrupted brain state dynamics in opioid and alcohol use disorder: attenuation by nicotine use;Neuropsychopharmacology;2023-11-07

5. The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review;Substance Abuse Treatment, Prevention, and Policy;2023-09-30